Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

Background. In patients with pulmonary hypertension, it is unknown whether the treatment effect of bosentan is dependent on the duration of pulmonary vessel changes. Therefore, we studied the response to bosentan in patients with life-long pulmonary vessel changes (pulmonary arterial hypertension (P...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Duffels, M.G.J., van der Plas, M.N., Surie, S., Winter, M.M., Bouma, B., Groenink, M., van Dijk, A.P.J., Hoendermis, E., Berger, R.M.F., Bresser, P., Mulder, B.J.M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bohn Stafleu van Loghum 2009
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758348/
https://ncbi.nlm.nih.gov/pubmed/19949475
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller